Skip to main content

Table 5 30-day Outcomes

From: Long-term outcome after mitral valve replacement using biological versus mechanical valves

 

Biological MVR

N = 265

Mechanical MVR

N = 59

Odds Ratio

95% CI

Adjusted Odds Ratioa

95% CI

Death, %

23/265 (8.7)

6/59 (10.2)

0.84 (0.33–2.16)

0.50 (0.17–1.52)

 Cardiac death, %

15/265 (5.7)

4/59 (6.8)

0.88 (0.28–2.75)

0.66 (0.18–2.42)

 Non-cardiac death, %

8/265 (3.0)

2/59 (3.4)

0.89 (0.18–4.29)

0.37 (0.06–2.32)

Stroke, %

11/265 (4.2)

2/59 (3.4)

1.23 (0.27–5.72)

0.47 (0.08–2.66)

Acute renal failure, %

27/265 (10.2)

7/59 (11.9)

0.85 (0.35–2.05)

0.45 (0.16–1.24)

Myocardial infarction, %

0/265 (0)

2/59 (3.4)

n.a.

n.a.

Pacemaker implantation, %

20/264 (7.6)

6/59 (10.2)

0.45 (0.16–1.29)

0.72 (0.28–1.89)

Re-thoracotomy, %

33/265 (12.5)

13/59 (22.0)

0.50 (0.25–1.03)

0.45 (0.20–1.00)

  1. Legend: Values are patients applicable/patients with available information with percentage in brackets
  2. n.a. not applicable
  3. aOdds ratios were calculated by logistic regression and adjusted for age, logistic EuroScore-I, CAD and MV insuff. ≥ grade II (preOP)